Montomoli E - Search Results

1

SARS-CoV-2 escape in vitro from a highly neutralizing COVID-19 convalescent plasma.

Andreano E, Piccini G, Licastro D, Casalino L, Johnson NV, Paciello I, Dal Monego S, Pantano E, Manganaro N, Manenti A, Manna R, Casa E, Hyseni I, Benincasa L, Montomoli E, Amaro RE, McLellan JS, Rappuoli R. Andreano E, et al. Among authors: montomoli e. bioRxiv [Preprint]. 2020 Dec 28:2020.12.28.424451. doi: 10.1101/2020.12.28.424451. bioRxiv. 2020. PMID: 33398278 Free PMC article. Updated. Preprint.

2

An unwanted guest: Neisseria meningitidis - carriage, risk for invasive disease and the impact of vaccination with insight on Italy incidence.

Gianchecchi E, Piccini G, Torelli A, Rappuoli R, Montomoli E. Gianchecchi E, et al. Among authors: montomoli e. Expert Rev Anti Infect Ther. 2017 Jul;15(7):689-701. doi: 10.1080/14787210.2017.1333422. Epub 2017 May 29. Expert Rev Anti Infect Ther. 2017. PMID: 28524748 Review.

3

Influenza Anti-Stalk Antibodies: Development of a New Method for the Evaluation of the Immune Responses to Universal Vaccine.

Manenti A, Maciola AK, Trombetta CM, Kistner O, Casa E, Hyseni I, Razzano I, Torelli A, Montomoli E. Manenti A, et al. Among authors: montomoli e. Vaccines (Basel). 2020 Jan 24;8(1):43. doi: 10.3390/vaccines8010043. Vaccines (Basel). 2020. PMID: 31991681 Free PMC article.

4

Evaluation of SARS-CoV-2 neutralizing antibodies using a CPE-based colorimetric live virus micro-neutralization assay in human serum samples.

Manenti A, Maggetti M, Casa E, Martinuzzi D, Torelli A, Trombetta CM, Marchi S, Montomoli E. Manenti A, et al. Among authors: montomoli e. J Med Virol. 2020 Oct;92(10):2096-2104. doi: 10.1002/jmv.25986. Epub 2020 May 17. J Med Virol. 2020. PMID: 32383254 Free PMC article.

5

Pathogenic signature of invasive non-typhoidal Salmonella in Africa: implications for vaccine development.

Piccini G, Montomoli E. Piccini G, et al. Among authors: montomoli e. Hum Vaccin Immunother. 2020 Sep 1;16(9):2056-2071. doi: 10.1080/21645515.2020.1785791. Epub 2020 Jul 21. Hum Vaccin Immunother. 2020. PMID: 32692622 Free PMC article. Review.

6

Characterisation of SARS-CoV-2 Lentiviral Pseudotypes and Correlation between Pseudotype-Based Neutralisation Assays and Live Virus-Based Micro Neutralisation Assays.

Hyseni I, Molesti E, Benincasa L, Piu P, Casa E, Temperton NJ, Manenti A, Montomoli E. Hyseni I, et al. Among authors: montomoli e. Viruses. 2020 Sep 10;12(9):1011. doi: 10.3390/v12091011. Viruses. 2020. PMID: 32927639 Free PMC article.

7

Unexpected detection of SARS-CoV-2 antibodies in the prepandemic period in Italy.

Apolone G, Montomoli E, Manenti A, Boeri M, Sabia F, Hyseni I, Mazzini L, Martinuzzi D, Cantone L, Milanese G, Sestini S, Suatoni P, Marchianò A, Bollati V, Sozzi G, Pastorino U. Apolone G, et al. Among authors: montomoli e. Tumori. 2021 Oct;107(5):446-451. doi: 10.1177/0300891620974755. Epub 2020 Nov 11. Tumori. 2021. PMID: 33176598 Free PMC article.

8

Comparative analyses of SARS-CoV-2 binding (IgG, IgM, IgA) and neutralizing antibodies from human serum samples.

Mazzini L, Martinuzzi D, Hyseni I, Benincasa L, Molesti E, Casa E, Lapini G, Piu P, Trombetta CM, Marchi S, Razzano I, Manenti A, Montomoli E. Mazzini L, et al. Among authors: montomoli e. J Immunol Methods. 2021 Feb;489:112937. doi: 10.1016/j.jim.2020.112937. Epub 2020 Nov 28. J Immunol Methods. 2021. PMID: 33253698 Free PMC article.

9

Extremely potent human monoclonal antibodies from COVID-19 convalescent patients.

Andreano E, Nicastri E, Paciello I, Pileri P, Manganaro N, Piccini G, Manenti A, Pantano E, Kabanova A, Troisi M, Vacca F, Cardamone D, De Santi C, Torres JL, Ozorowski G, Benincasa L, Jang H, Di Genova C, Depau L, Brunetti J, Agrati C, Capobianchi MR, Castilletti C, Emiliozzi A, Fabbiani M, Montagnani F, Bracci L, Sautto G, Ross TM, Montomoli E, Temperton N, Ward AB, Sala C, Ippolito G, Rappuoli R. Andreano E, et al. Among authors: montomoli e. Cell. 2021 Apr 1;184(7):1821-1835.e16. doi: 10.1016/j.cell.2021.02.035. Epub 2021 Feb 23. Cell. 2021. PMID: 33667349 Free PMC article.

10

Serum Neutralizing Activity against B.1.1.7, B.1.351, and P.1 SARS-CoV-2 Variants of Concern in Hospitalized COVID-19 Patients.

Trombetta CM, Marchi S, Viviani S, Manenti A, Benincasa L, Ruello A, Bombardieri E, Vicenti I, Zazzi M, Montomoli E. Trombetta CM, et al. Among authors: montomoli e. Viruses. 2021 Jul 12;13(7):1347. doi: 10.3390/v13071347. Viruses. 2021. PMID: 34372553 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

210 results

Search Page